Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Update on Neurogen's schizophrenia program

April 18, 1997

Pfizer characterizes new antipsychotic agent

April 17, 1997

Pfizer describes substance P antagonists

April 17, 1997

Excitatory amino acid antagonists from Novartis

April 17, 1997

Pharmacia & Upjohn describes agents for 5-HT1A receptor-mediated disorders

April 17, 1997

SKB describes 5-HT2C/5-HT2B antagonists

April 17, 1997

5-HT2 antagonists/5-HT reuptake inhibitors described by Yamanouchi

April 16, 1997

Nasal midazolam safe and effective for anterograde amnesia in children undergoing VCUG

April 15, 1997

DuPont Merck reports orally active acetylcholine release enhancer

April 15, 1997

Novel dopamine receptor ligands from Purdue Research Foundation/UNC

April 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...